Back to Trials
NCT05889624NARecruiting

Responding With Evidence and Access for Childhood Headaches

Children's Hospital Medical Center, Cincinnati

Start Date

8/22/2023

Completion Date

12/31/2027

Summary

This comparative effectiveness study will clarify current first-line preventive treatment approaches for use by neurologists, psychologists, and primary care providers in the context of real world care, and will demonstrate the feasibility of Cognitive Behavioral Therapy (CBT) via telehealth for youth with migraine. The focus is on applying evidence-based care and enhancing access to it. CBT via telehealth while taking a clinically-prescribed, pill-based prevention therapy (amitriptyline) will be compared to CBT via telehealth alone.

Detailed Description

Migraine is the second most disabling disease in the world. Research has primarily focused on treating migraine in adults; however, approximately 10% of children and adolescents have migraine, suggesting that up to 7 million youth are impacted in the United States alone. Given that the majority of youth have migraine symptoms that persist into adulthood, there is a critical need to identify and improve access to the most effective preventive migraine treatments for this population as a means of reducing the long-term healthcare burden and functional impairment of this illness. This comparative effectiveness study will test CBT while taking a clinically-prescribed, pill-based prevention therapy (amitriptyline) to CBT alone. Participants will be involved in the study for approximately 28 weeks, with the first 4 weeks being a baseline period and the next 8 weeks involving six telehealth CBT sessions for both study groups (CBT while taking a clinically-prescribed pill-based prevention therapy \[amitriptyline\] compared to CBT alone), and dose titration of clinically-prescribed medication (amitriptyline) for the CBT + clinically-prescribed, pill-based prevention therapy (amitriptyline) group. During the remaining 16 weeks the participants will maintain the dose of medication (in the CBT + clinically-prescribed, pill-based prevention therapy (amitriptyline) group) and attend "booster" CBT sessions held three times over 4 months.

Eligibility Criteria

Age Range: 10 years to 17 years

Inclusion Criteria: * Diagnosis: Migraine with or without aura that meets the International Classification of Headache Disorders (ICHD) criteria 5 or presentation of continuous headache that includes migranous episodes based upon headache history obtained by site PI or designee. (includes presentation with or without medication overuse headache as well) * Headache Frequency: 4 or more headache days based upon prospective headache diary of 28 days prior to randomization * Amitriptyline Eligible: Site PI or medical staff determined participant to be eligible for clinical prescription of amitriptyline as a preventive treatment for migraine * English fluency: Able to complete the study visits and questionnaires in English Exclusion Criteria: * Current treatment includes amitriptyline and/or CBT specific to headache care * Current prescribed preventive antimigraine medication within a period equivalent to \< 5 half-lives of that medication before entering the baseline phase * Current treatment with onabotulinumtoxinA (Botox) or CGRP-based monoclonal antibody medications for migraine prevention * Youth who are pregnant * Report of current or ongoing suicidal thoughts. Suicide attempt within the past six months. History of bipolar disorder, prolonged QT, or pre-existing significant constipation or gastroparesis * Any and all other diagnoses or conditions which, in the opinion of the site investigator, would prevent the patient from being a suitable candidate for the study or interfere with the medical care needs of the participant

Interventions

BEHAVIORAL

CBT

DRUG

Amitriptyline

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

HeadacheHeadache DisordersHeadache, MigraineMigraineMigraine DisordersMigraine With AuraMigraine Without AuraChronic Migraine

Locations

University of Alabama at Birmingham Children's of Alabama

Birmingham, Alabama 35233

United States

Phoenix Children's Hospital - Barrow Neurological Institute

Phoenix, Arizona 85016-7710

United States

University of California San Francisco

San Francisco, California 94115

United States

University of Colorado/Children's Hospital Colorado

Aurora, Colorado 80045

United States

Nemours Children's Health System

Wilmington, Delaware 19810

United States

Clinical Integrative Research Center of Atlanta, Inc

Atlanta, Georgia 30328

United States

University of Louisville Health/Norton

Louisville, Kentucky 40292

United States

Louisiana State Univ/Children's Hospital of New Orleans

New Orleans, Louisiana 70118-5720

United States

Dent Neurological Institute

Amherst, New York 14226

United States

Cincinnati Children's Hospital Medical Center

Cincinnati, Ohio 45229

United States

Nationwide Childrens

Columbus, Ohio 43205

United States

Children's Hospital of Philadelphia

Philadelphia, Pennsylvania 19104

United States

University of Tennessee Health Science Center/ LeBonheur Children's Hospital

Memphis, Tennessee 38103

United States

Dell Children's Hospital-UT Health

Austin, Texas 78712

United States

Marshall Health

Huntington, West Virginia 25701

United States